Gilead (GILD) Reports Q3 Earnings: What Key Metrics Have to Say

Gilead Sciences (GILD) reported $7.55 billion in revenue for the quarter ended September 2024, representing a year-over-year increase of 7$2.02 for the same period compares to $2.29 a year ago. The reported revenue compares to the Zacks Consensus Estimate of$6.99 billion, representing a surprise of +7.94%. The company delivered an EPS surprise of +27.85%, with the consensus EPS estimate being $1.58. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings - ...